210
Participants
Start Date
December 31, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
July 31, 2013
SBI-087
200 mg SC Day 1, Placebo Day 15, Placebo Day 84 + Methotrexate
SBI-087
200 mg SC Day 1, 200 mg SC Day 15, Placebo Day 84 + Methotrexate
SBI-087
200 mg SC Day 1, Placebo Day 15, 200 mg SC Day 84 + Methotrexate
SBI-087
200 mg SC Day 1, 200 mg SC Day 15, 200 mg SC Day 84 + Methotrexate
Placebo
Placebo Day 1, Placebo Day 15, Placebo Day 84 + Methotrexate
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Miskolc
Pfizer Investigational Site, Szolnok
Pfizer Investigational Site, Gyula
Pfizer Investigational Site, Belgrade
Pfizer Investigational Site, Syracuse
Pfizer Investigational Site, A Coruña
Pfizer Investigational Site, Niška Banja
Pfizer Investigational Site, Newark
Pfizer Investigational Site, Novi Sad
Pfizer Investigational Site, Clarksburg
Pfizer Investigational Site, Coahulia
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Palm Harbor
Pfizer Investigational Site, Jackson
Pfizer Investigational Site, Seville
Pfizer Investigational Site, Toledo
Pfizer Investigational Site, Dayton
Pfizer Investigational Site, Grand Rapids
Pfizer Investigational Site, Minot
Pfizer Investigational Site, Springfield
Pfizer Investigational Site, Tulsa
Pfizer Investigational Site, Paradise Valley
Pfizer Investigational Site, Albuquerque
Pfizer Investigational Site, Santa Monica
Pfizer Investigational Site, Westlake Village
Pfizer Investigational Site, Palm Desert
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, Providencia
Pfizer Investigational Site, Worcester
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, C.a.b.a
Pfizer Investigational Site, C.a.b.a
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Pointe-Claire
Pfizer Investigational Site, Aichi
Pfizer Investigational Site, Fukui
Pfizer Investigational Site, Fukuoka
Pfizer Investigational Site, Hokkaido
Pfizer Investigational Site, Hyōgo
Pfizer Investigational Site, Kanagawa
Pfizer Investigational Site, Miyagi
Pfizer Investigational Site, Saitama
Pfizer Investigational Site, Shizuoka
Pfizer Investigational Site, Tokyo
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Działdowo
Pfizer Investigational Site, Elblag
Pfizer Investigational Site, Sopot
Pfizer Investigational Site, Warsaw
Lead Sponsor
Emergent Product Development Seattle LLC
INDUSTRY
Pfizer
INDUSTRY